Abstract
Near-infrared has been a staple in many industries for over four decades but has lagged behind in the other, consumer-based industries. One reason is that the Pharma industry is highly regulated and producers have been hesitant to attempt any changes. Since 2004, numerous guidances from the FDA and EMA, along with guidelines from the International Council for Harmonisation, have encouraged and, in reality, given permission to the Pharma industry to enter the 21st century. Together with financial pressures, available technologies are moving the industry to new levels of quality and safety (and profit).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
